1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Antidepressants Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Tricyclic Antidepressants 1.2.3 Selective Serotonin Reuptake Inhibitors 1.2.4 Selective Norepinephrine Reuptake Inhibitors 1.2.5 Monoamine Oxidase Inhibitors 1.2.6 Benzodiazepines 1.2.7 Antipsychotics 1.2.8 Novel Agents 1.3 Market Segment by Application 1.3.1 Global Antidepressants Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Antidepressants Market Size (2017-2028) 2.1.1 Global Antidepressants Revenue (2017-2028) 2.1.2 Global Antidepressants Sales (2017-2028) 2.2 Global Antidepressants Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Antidepressants Sales by Regions (2017-2022) 2.2.2 Global Antidepressants Revenue by Regions (2017-2022) 2.3 Global Antidepressants Market Size Forecast by Region 2.3.1 Global Antidepressants Sales Forecast by Region (2023-2028) 2.3.2 Global Antidepressants Revenue Forecast by Region (2023-2028) 2.4 Global Top Antidepressants Regions (Countries) Ranking by Market Size 2.5 Antidepressants Market Dynamics 2.5.1 Antidepressants Market Trends 2.5.2 Antidepressants Market Drivers 2.5.3 Antidepressants Market Challenges 2.5.4 Antidepressants Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Antidepressants Manufacturers by Sales (2017-2022) 3.1.1 Global Antidepressants Sales by Manufacturers (2017-2022) 3.1.2 Global Antidepressants Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Antidepressants Sales in 2021 3.2 Global Top Manufacturers Antidepressants by Revenue 3.2.1 Global Antidepressants Revenue by Manufacturers (2017-2022) 3.2.2 Top Antidepressants Manufacturers Covered: Ranking by Revenue 3.2.3 Global Antidepressants Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Antidepressants Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidepressants as of 2021) 3.4 Global Antidepressants Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Antidepressants Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Antidepressants Market 3.7 Key Manufacturers Antidepressants Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Antidepressants Market Size by Type 4.1 Global Antidepressants Historic Market Review by Type (2017-2022) 4.1.1 Global Antidepressants Sales Market Share by Type (2017-2022) 4.1.2 Global Antidepressants Revenue Market Share by Type (2017-2022) 4.1.3 Antidepressants Price by Type (2017-2022) 4.2 Global Antidepressants Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Antidepressants Sales Forecast by Type (2023-2028) 4.2.2 Global Antidepressants Revenue Forecast by Type (2023-2028) 4.2.3 Antidepressants Price Forecast by Type (2023-2028) 5 Global Antidepressants Market Size by Application 5.1 Global Antidepressants Historic Market Review by Application (2017-2022) 5.1.1 Global Antidepressants Sales Market Share by Application (2017-2022) 5.1.2 Global Antidepressants Revenue Market Share by Application (2017-2022) 5.1.3 Antidepressants Price by Application (2017-2022) 5.2 Global Antidepressants Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Antidepressants Sales Forecast by Application (2023-2028) 5.2.2 Global Antidepressants Revenue Forecast by Application (2023-2028) 5.2.3 Antidepressants Price Forecast by Application (2023-2028) 6 North America 6.1 North America Antidepressants Sales Breakdown by Company 6.1.1 North America Antidepressants Sales by Company (2017-2022) 6.1.2 North America Antidepressants Revenue by Company (2017-2022) 6.2 North America Antidepressants Market Size by Type 6.2.1 North America Antidepressants Sales by Type (2017-2028) 6.2.2 North America Antidepressants Revenue by Type (2017-2028) 6.3 North America Antidepressants Market Size by Application 6.3.1 North America Antidepressants Sales by Application (2017-2028) 6.3.2 North America Antidepressants Revenue by Application (2017-2028) 6.4 North America Antidepressants Market Size by Country 6.4.1 North America Antidepressants Sales by Country (2017-2028) 6.4.2 North America Antidepressants Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Antidepressants Sales Breakdown by Company 7.1.1 Europe Antidepressants Sales by Company (2017-2022) 7.1.2 Europe Antidepressants Revenue by Company (2017-2022) 7.2 Europe Antidepressants Market Size by Type 7.2.1 Europe Antidepressants Sales by Type (2017-2028) 7.2.2 Europe Antidepressants Revenue by Type (2017-2028) 7.3 Europe Antidepressants Market Size by Application 7.3.1 Europe Antidepressants Sales by Application (2017-2028) 7.3.2 Europe Antidepressants Revenue by Application (2017-2028) 7.4 Europe Antidepressants Market Size by Country 7.4.1 Europe Antidepressants Sales by Country (2017-2028) 7.4.2 Europe Antidepressants Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Antidepressants Sales Breakdown by Company 8.1.1 Asia Pacific Antidepressants Sales by Company (2017-2022) 8.1.2 Asia Pacific Antidepressants Revenue by Company (2017-2022) 8.2 Asia Pacific Antidepressants Market Size by Type 8.2.1 Asia Pacific Antidepressants Sales by Type (2017-2028) 8.2.2 Asia Pacific Antidepressants Revenue by Type (2017-2028) 8.3 Asia Pacific Antidepressants Market Size by Application 8.3.1 Asia Pacific Antidepressants Sales by Application (2017-2028) 8.3.2 Asia Pacific Antidepressants Revenue by Application (2017-2028) 8.4 Asia Pacific Antidepressants Market Size by Region 8.4.1 Asia Pacific Antidepressants Sales by Region 8.4.2 Asia Pacific Antidepressants Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Antidepressants Sales Breakdown by Company 9.1.1 Latin America Antidepressants Sales by Company (2017-2022) 9.1.2 Latin America Antidepressants Revenue by Company (2017-2022) 9.2 Latin America Antidepressants Market Size by Type 9.2.1 Latin America Antidepressants Sales by Type (2017-2028) 9.2.2 Latin America Antidepressants Revenue by Type (2017-2028) 9.3 Latin America Antidepressants Market Size by Application 9.3.1 Latin America Antidepressants Sales by Application (2017-2028) 9.3.2 Latin America Antidepressants Revenue by Application (2017-2028) 9.4 Latin America Antidepressants Market Size by Country 9.4.1 Latin America Antidepressants Sales by Country (2017-2028) 9.4.2 Latin America Antidepressants Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Antidepressants Sales Breakdown by Company 10.1.1 Middle East and Africa Antidepressants Sales by Company (2017-2022) 10.1.2 Middle East and Africa Antidepressants Revenue by Company (2017-2022) 10.2 Middle East and Africa Antidepressants Market Size by Type 10.2.1 Middle East and Africa Antidepressants Sales by Type (2017-2028) 10.2.2 Middle East and Africa Antidepressants Revenue by Type (2017-2028) 10.3 Middle East and Africa Antidepressants Market Size by Application 10.3.1 Middle East and Africa Antidepressants Sales by Application (2017-2028) 10.3.2 Middle East and Africa Antidepressants Revenue by Application (2017-2028) 10.4 Middle East and Africa Antidepressants Market Size by Country 10.4.1 Middle East and Africa Antidepressants Sales by Country (2017-2028) 10.4.2 Middle East and Africa Antidepressants Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 H Lundbeck 11.1.1 H Lundbeck Corporation Information 11.1.2 H Lundbeck Overview 11.1.3 H Lundbeck Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 H Lundbeck Antidepressants Products and Services 11.1.5 H Lundbeck Antidepressants SWOT Analysis 11.1.6 H Lundbeck Recent Developments 11.2 Astrazeneca 11.2.1 Astrazeneca Corporation Information 11.2.2 Astrazeneca Overview 11.2.3 Astrazeneca Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Astrazeneca Antidepressants Products and Services 11.2.5 Astrazeneca Antidepressants SWOT Analysis 11.2.6 Astrazeneca Recent Developments 11.3 Eli Lilly and Company 11.3.1 Eli Lilly and Company Corporation Information 11.3.2 Eli Lilly and Company Overview 11.3.3 Eli Lilly and Company Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Eli Lilly and Company Antidepressants Products and Services 11.3.5 Eli Lilly and Company Antidepressants SWOT Analysis 11.3.6 Eli Lilly and Company Recent Developments 11.4 Sun Pharmaceuticals 11.4.1 Sun Pharmaceuticals Corporation Information 11.4.2 Sun Pharmaceuticals Overview 11.4.3 Sun Pharmaceuticals Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Sun Pharmaceuticals Antidepressants Products and Services 11.4.5 Sun Pharmaceuticals Antidepressants SWOT Analysis 11.4.6 Sun Pharmaceuticals Recent Developments 11.5 Pfizer Inc. 11.5.1 Pfizer Inc. Corporation Information 11.5.2 Pfizer Inc. Overview 11.5.3 Pfizer Inc. Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Pfizer Inc. Antidepressants Products and Services 11.5.5 Pfizer Inc. Antidepressants SWOT Analysis 11.5.6 Pfizer Inc. Recent Developments 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Corporation Information 11.6.2 GlaxoSmithKline Overview 11.6.3 GlaxoSmithKline Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 GlaxoSmithKline Antidepressants Products and Services 11.6.5 GlaxoSmithKline Antidepressants SWOT Analysis 11.6.6 GlaxoSmithKline Recent Developments 11.7 Bristol-Myers Squibb Company 11.7.1 Bristol-Myers Squibb Company Corporation Information 11.7.2 Bristol-Myers Squibb Company Overview 11.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Bristol-Myers Squibb Company Antidepressants Products and Services 11.7.5 Bristol-Myers Squibb Company Antidepressants SWOT Analysis 11.7.6 Bristol-Myers Squibb Company Recent Developments 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Corporation Information 11.8.2 Johnson & Johnson Overview 11.8.3 Johnson & Johnson Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Johnson & Johnson Antidepressants Products and Services 11.8.5 Johnson & Johnson Antidepressants SWOT Analysis 11.8.6 Johnson & Johnson Recent Developments 11.9 Merck 11.9.1 Merck Corporation Information 11.9.2 Merck Overview 11.9.3 Merck Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Merck Antidepressants Products and Services 11.9.5 Merck Antidepressants SWOT Analysis 11.9.6 Merck Recent Developments 11.10 Sanofi 11.10.1 Sanofi Corporation Information 11.10.2 Sanofi Overview 11.10.3 Sanofi Antidepressants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Sanofi Antidepressants Products and Services 11.10.5 Sanofi Antidepressants SWOT Analysis 11.10.6 Sanofi Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Antidepressants Value Chain Analysis 12.2 Antidepressants Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Antidepressants Production Mode & Process 12.4 Antidepressants Sales and Marketing 12.4.1 Antidepressants Sales Channels 12.4.2 Antidepressants Distributors 12.5 Antidepressants Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Antidepressants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Tricyclic Antidepressants Table 3. Major Manufacturers of Selective Serotonin Reuptake Inhibitors Table 4. Major Manufacturers of Selective Norepinephrine Reuptake Inhibitors Table 5. Major Manufacturers of Monoamine Oxidase Inhibitors Table 6. Major Manufacturers of Benzodiazepines Table 7. Major Manufacturers of Antipsychotics Table 8. Major Manufacturers of Novel Agents Table 9. Global Antidepressants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 10. Global Antidepressants Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 11. Global Antidepressants Sales by Region (2017-2022) & (K Units) Table 12. Global Antidepressants Sales Market Share by Region (2017-2022) Table 13. Global Antidepressants Revenue by Region (2017-2022) & (US$ Million) Table 14. Global Antidepressants Revenue Market Share by Region (2017-2022) Table 15. Global Antidepressants Sales Forecast by Region (2023-2028) & (K Units) Table 16. Global Antidepressants Sales Market Share Forecast by Region (2023-2028) Table 17. Global Antidepressants Revenue Forecast by Region (2023-2028) & (US$ Million) Table 18. Global Antidepressants Revenue Market Share Forecast by Region (2023-2028) Table 19. Top Antidepressants Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 20. Antidepressants Market Trends Table 21. Antidepressants Market Drivers Table 22. Antidepressants Market Challenges Table 23. Antidepressants Market Restraints Table 24. Global Antidepressants Sales by Manufacturers (2017-2022) & (K Units) Table 25. Global Antidepressants Sales Share by Manufacturers (2017-2022) Table 26. Global Antidepressants Revenue by Manufacturers (2017-2022) & (US$ Million) Table 27. Ranking of Global Top Antidepressants Manufacturers by Revenue (US$ Million) in 2021 Table 28. Antidepressants Revenue Share by Manufacturers (2017-2022) Table 29. Global Antidepressants Manufacturers Market Concentration Ratio (CR5 and HHI) Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidepressants as of 2021) Table 31. Key Manufacturers Antidepressants Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 32. Key Manufacturers Antidepressants Plants/Factories Distribution Table 33. Key Manufacturers Antidepressants Area Served Table 34. Date of Key Manufacturers Enter into Antidepressants Market Table 35. Key Manufacturers Antidepressants Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Antidepressants Sales (K Units) by Type (2017-2022) Table 38. Global Antidepressants Sales Share by Type (2017-2022) Table 39. Global Antidepressants Revenue (US$ Million) Market Share by Type (2017-2022) Table 40. Global Antidepressants Price (K Units) by Type (2017-2022) Table 41. Global Antidepressants Sales (K Units) by Type (2023-2028) Table 42. Global Antidepressants Sales Share by Type (2023-2028) Table 43. Global Antidepressants Revenue (US$ Million) Market Share by Type (2023-2028) Table 44. Global Antidepressants Revenue Share by Type (2023-2028) Table 45. Global Antidepressants Price (K Units) by Type (2023-2028) Table 46. Global Antidepressants Sales (K Units) by Application (2017-2022) Table 47. Global Antidepressants Sales Share by Application (2017-2022) Table 48. Global Antidepressants Revenue (US$ Million) Market Share by Application (2017-2022) Table 49. Global Antidepressants Price (K Units) by Application (2017-2022) Table 50. Global Antidepressants Sales (K Units) by Application (2023-2028) Table 51. Global Antidepressants Sales Share by Application (2023-2028) Table 52. Global Antidepressants Revenue (US$ Million) Market Share by Application (2023-2028) Table 53. Global Antidepressants Revenue Share by Application (2023-2028) Table 54. Global Antidepressants Price (K Units) by Application (2023-2028) Table 55. North America Antidepressants Sales by Company (2017-2022) & (K Units) Table 56. North America Antidepressants Sales Market Share by Company (2017-2022) Table 57. North America Antidepressants Revenue by Company (2017-2022) & (US$ Million) Table 58. North America Antidepressants Revenue Market Share by Company (2017-2022) Table 59. North America Antidepressants Sales by Type (2017-2022) & (K Units) Table 60. North America Antidepressants Sales by Type (2023-2028) & (K Units) Table 61. North America Antidepressants Revenue by Type (2017-2022) & (US$ Million) Table 62. North America Antidepressants Revenue by Type (2023-2028) & (US$ Million) Table 63. North America Antidepressants Sales by Application (2017-2022) & (K Units) Table 64. North America Antidepressants Sales by Application (2023-2028) & (K Units) Table 65. North America Antidepressants Revenue by Application (2017-2022) & (US$ Million) Table 66. North America Antidepressants Revenue by Application (2023-2028) & (US$ Million) Table 67. North America Antidepressants Sales by Country (2017-2022) & (K Units) Table 68. North America Antidepressants Sales by Country (2023-2028) & (K Units) Table 69. North America Antidepressants Revenue by Country (2017-2022) & (US$ Million) Table 70. North America Antidepressants Revenue by Country (2023-2028) & (US$ Million) Table 71. Europe Antidepressants Sales by Company (2017-2022) & (K Units) Table 72. Europe Antidepressants Sales Market Share by Company (2017-2022) Table 73. Europe Antidepressants Revenue by Company (2017-2022) & (US$ Million) Table 74. Europe Antidepressants Revenue Market Share by Company (2017-2022) Table 75. Europe Antidepressants Sales by Type (2017-2022) & (K Units) Table 76. Europe Antidepressants Sales by Type (2023-2028) & (K Units) Table 77. Europe Antidepressants Revenue by Type (2017-2022) & (US$ Million) Table 78. Europe Antidepressants Revenue by Type (2023-2028) & (US$ Million) Table 79. Europe Antidepressants Sales by Application (2017-2022) & (K Units) Table 80. Europe Antidepressants Sales by Application (2023-2028) & (K Units) Table 81. Europe Antidepressants Revenue by Application (2017-2022) & (US$ Million) Table 82. Europe Antidepressants Revenue by Application (2023-2028) & (US$ Million) Table 83. Europe Antidepressants Sales by Country (2017-2022) & (K Units) Table 84. Europe Antidepressants Sales by Country (2023-2028) & (K Units) Table 85. Europe Antidepressants Revenue by Country (2017-2022) & (US$ Million) Table 86. Europe Antidepressants Revenue by Country (2023-2028) & (US$ Million) Table 87. Asia Pacific Antidepressants Sales by Company (2017-2022) & (K Units) Table 88. Asia Pacific Antidepressants Sales Market Share by Company (2017-2022) Table 89. Asia Pacific Antidepressants Revenue by Company (2017-2022) & (US$ Million) Table 90. Asia Pacific Antidepressants Revenue Market Share by Company (2017-2022) Table 91. Asia Pacific Antidepressants Sales by Type (2017-2022) & (K Units) Table 92. Asia Pacific Antidepressants Sales by Type (2023-2028) & (K Units) Table 93. Asia Pacific Antidepressants Revenue by Type (2017-2022) & (US$ Million) Table 94. Asia Pacific Antidepressants Revenue by Type (2023-2028) & (US$ Million) Table 95. Asia Pacific Antidepressants Sales by Application (2017-2022) & (K Units) Table 96. Asia Pacific Antidepressants Sales by Application (2023-2028) & (K Units) Table 97. Asia Pacific Antidepressants Revenue by Application (2017-2022) & (US$ Million) Table 98. Asia Pacific Antidepressants Revenue by Application (2023-2028) & (US$ Million) Table 99. Asia Pacific Antidepressants Sales by Region (2017-2022) & (K Units) Table 100. Asia Pacific Antidepressants Sales by Region (2023-2028) & (K Units) Table 101. Asia Pacific Antidepressants Revenue by Region (2017-2022) & (US$ Million) Table 102. Asia Pacific Antidepressants Revenue by Region (2023-2028) & (US$ Million) Table 103. Latin America Antidepressants Sales by Company (2017-2022) & (K Units) Table 104. Latin America Antidepressants Sales Market Share by Company (2017-2022) Table 105. Latin America Antidepressants Revenue by Company (2017-2022) & (US$ Million) Table 106. Latin America Antidepressants Revenue Market Share by Company (2017-2022) Table 107. Latin America Antidepressants Sales by Type (2017-2022) & (K Units) Table 108. Latin America Antidepressants Sales by Type (2023-2028) & (K Units) Table 109. Latin America Antidepressants Revenue by Type (2017-2022) & (US$ Million) Table 110. Latin America Antidepressants Revenue by Type (2023-2028) & (US$ Million) Table 111. Latin America Antidepressants Sales by Application (2017-2022) & (K Units) Table 112. Latin America Antidepressants Sales by Application (2023-2028) & (K Units) Table 113. Latin America Antidepressants Revenue by Application (2017-2022) & (US$ Million) Table 114. Latin America Antidepressants Revenue by Application (2023-2028) & (US$ Million) Table 115. Latin America Antidepressants Sales by Country (2017-2022) & (K Units) Table 116. Latin America Antidepressants Sales by Country (2023-2028) & (K Units) Table 117. Latin America Antidepressants Revenue by Country (2017-2022) & (US$ Million) Table 118. Latin America Antidepressants Revenue by Country (2023-2028) & (US$ Million) Table 119. Middle East and Africa Antidepressants Sales by Company (2017-2022) & (K Units) Table 120. Middle East and Africa Antidepressants Sales Market Share by Company (2017-2022) Table 121. Middle East and Africa Antidepressants Revenue by Company (2017-2022) & (US$ Million) Table 122. Middle East and Africa Antidepressants Revenue Market Share by Company (2017-2022) Table 123. Middle East and Africa Antidepressants Sales by Type (2017-2022) & (K Units) Table 124. Middle East and Africa Antidepressants Sales by Type (2023-2028) & (K Units) Table 125. Middle East and Africa Antidepressants Revenue by Type (2017-2022) & (US$ Million) Table 126. Middle East and Africa Antidepressants Revenue by Type (2023-2028) & (US$ Million) Table 127. Middle East and Africa Antidepressants Sales by Application (2017-2022) & (K Units) Table 128. Middle East and Africa Antidepressants Sales by Application (2023-2028) & (K Units) Table 129. Middle East and Africa Antidepressants Revenue by Application (2017-2022) & (US$ Million) Table 130. Middle East and Africa Antidepressants Revenue by Application (2023-2028) & (US$ Million) Table 131. Middle East and Africa Antidepressants Sales by Country (2017-2022) & (K Units) Table 132. Middle East and Africa Antidepressants Sales by Country (2023-2028) & (K Units) Table 133. Middle East and Africa Antidepressants Revenue by Country (2017-2022) & (US$ Million) Table 134. Middle East and Africa Antidepressants Revenue by Country (2023-2028) & (US$ Million) Table 135. H Lundbeck Corporation Information Table 136. H Lundbeck Description and Overview Table 137. H Lundbeck Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 138. H Lundbeck Antidepressants Product and Services Table 139. H Lundbeck Antidepressants SWOT Analysis Table 140. H Lundbeck Recent Developments Table 141. Astrazeneca Corporation Information Table 142. Astrazeneca Description and Overview Table 143. Astrazeneca Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 144. Astrazeneca Antidepressants Product and Services Table 145. Astrazeneca Antidepressants SWOT Analysis Table 146. Astrazeneca Recent Developments Table 147. Eli Lilly and Company Corporation Information Table 148. Eli Lilly and Company Description and Overview Table 149. Eli Lilly and Company Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 150. Eli Lilly and Company Antidepressants Product and Services Table 151. Eli Lilly and Company Antidepressants SWOT Analysis Table 152. Eli Lilly and Company Recent Developments Table 153. Sun Pharmaceuticals Corporation Information Table 154. Sun Pharmaceuticals Description and Overview Table 155. Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 156. Sun Pharmaceuticals Antidepressants Product and Services Table 157. Sun Pharmaceuticals Antidepressants SWOT Analysis Table 158. Sun Pharmaceuticals Recent Developments Table 159. Pfizer Inc. Corporation Information Table 160. Pfizer Inc. Description and Overview Table 161. Pfizer Inc. Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 162. Pfizer Inc. Antidepressants Product and Services Table 163. Pfizer Inc. Antidepressants SWOT Analysis Table 164. Pfizer Inc. Recent Developments Table 165. GlaxoSmithKline Corporation Information Table 166. GlaxoSmithKline Description and Overview Table 167. GlaxoSmithKline Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 168. GlaxoSmithKline Antidepressants Product and Services Table 169. GlaxoSmithKline Antidepressants SWOT Analysis Table 170. GlaxoSmithKline Recent Developments Table 171. Bristol-Myers Squibb Company Corporation Information Table 172. Bristol-Myers Squibb Company Description and Overview Table 173. Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 174. Bristol-Myers Squibb Company Antidepressants Product and Services Table 175. Bristol-Myers Squibb Company Antidepressants SWOT Analysis Table 176. Bristol-Myers Squibb Company Recent Developments Table 177. Johnson & Johnson Corporation Information Table 178. Johnson & Johnson Description and Overview Table 179. Johnson & Johnson Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 180. Johnson & Johnson Antidepressants Product and Services Table 181. Johnson & Johnson Antidepressants SWOT Analysis Table 182. Johnson & Johnson Recent Developments Table 183. Merck Corporation Information Table 184. Merck Description and Overview Table 185. Merck Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 186. Merck Antidepressants Product and Services Table 187. Merck Antidepressants SWOT Analysis Table 188. Merck Recent Developments Table 189. Sanofi Corporation Information Table 190. Sanofi Description and Overview Table 191. Sanofi Antidepressants Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 192. Sanofi Antidepressants Product and Services Table 193. Sanofi Antidepressants SWOT Analysis Table 194. Sanofi Recent Developments Table 195. Key Raw Materials Lists Table 196. Raw Materials Key Suppliers Lists Table 197. Antidepressants Distributors List Table 198. Antidepressants Customers List Table 199. Research Programs/Design for This Report Table 200. Key Data Information from Secondary Sources Table 201. Key Data Information from Primary Sources List of Figures Figure 1. Antidepressants Product Picture Figure 2. Global Antidepressants Sales Market Share by Type in 2021 & 2028 Figure 3. Tricyclic Antidepressants Product Picture Figure 4. Selective Serotonin Reuptake Inhibitors Product Picture Figure 5. Selective Norepinephrine Reuptake Inhibitors Product Picture Figure 6. Monoamine Oxidase Inhibitors Product Picture Figure 7. Benzodiazepines Product Picture Figure 8. Antipsychotics Product Picture Figure 9. Novel Agents Product Picture Figure 10. Global Antidepressants Sales Market Share by Application in 2021 & 2028 Figure 11. Hospitals Use Case Figure 12. Clinics Use Case Figure 13. Other Use Case Figure 14. Antidepressants Report Years Considered Figure 15. Global Antidepressants Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Antidepressants Market Size 2017-2028 (US$ Million) Figure 17. Global Antidepressants Sales (2017-2022) & (K Units) Figure 18. Global Antidepressants Market Size Market Share by Region: 2021 VS 2028 Figure 19. Global Antidepressants Sales Market Share by Region (2017-2022) Figure 20. Global Antidepressants Sales Market Share by Region in 2021 Figure 21. Global Antidepressants Revenue Market Share by Region in 2017 VS 2021 Figure 22. Global Antidepressants Sales Share by Manufacturers in 2021 Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidepressants Sales in 2021 Figure 24. Antidepressants Revenue Share by Manufacturers in 2021 Figure 25. Antidepressants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 26. Global Antidepressants Revenue Share by Type (2017-2022) Figure 27. Global Antidepressants Revenue Growth Rate by Type in 2017 & 2021 Figure 28. Global Antidepressants Revenue Share by Application (2017-2022) Figure 29. Global Antidepressants Revenue Growth Rate by Application in 2017 & 2021 Figure 30. North America Antidepressants Sales Market Share by Type (2017-2028) Figure 31. North America Antidepressants Revenue Market Share by Type (2017-2028) Figure 32. North America Antidepressants Sales Market Share by Application (2017-2028) Figure 33. North America Antidepressants Revenue Market Share by Application (2017-2028) Figure 34. North America Antidepressants Sales Share by Country (2017-2028) Figure 35. North America Antidepressants Revenue Share by Country (2017-2028) Figure 36. U.S. Antidepressants Revenue (2017-2028) & (US$ Million) Figure 37. Canada Antidepressants Revenue (2017-2028) & (US$ Million) Figure 38. Europe Antidepressants Sales Market Share by Type (2017-2028) Figure 39. Europe Antidepressants Revenue Market Share by Type (2017-2028) Figure 40. Europe Antidepressants Sales Market Share by Application (2017-2028) Figure 41. Europe Antidepressants Revenue Market Share by Application (2017-2028) Figure 42. Europe Antidepressants Sales Share by Country (2017-2028) Figure 43. Europe Antidepressants Revenue Share by Country (2017-2028) Figure 44. Germany Antidepressants Revenue (2017-2028) & (US$ Million) Figure 45. France Antidepressants Revenue (2017-2028) & (US$ Million) Figure 46. U.K. Antidepressants Revenue (2017-2028) & (US$ Million) Figure 47. Italy Antidepressants Revenue (2017-2028) & (US$ Million) Figure 48. Russia Antidepressants Revenue (2017-2028) & (US$ Million) Figure 49. Asia Pacific Antidepressants Sales Market Share by Type (2017-2028) Figure 50. Asia Pacific Antidepressants Revenue Market Share by Type (2017-2028) Figure 51. Asia Pacific Antidepressants Sales Market Share by Application (2017-2028) Figure 52. Asia Pacific Antidepressants Revenue Market Share by Application (2017-2028) Figure 53. Asia Pacific Antidepressants Sales Share by Region (2017-2028) Figure 54. Asia Pacific Antidepressants Revenue Share by Region (2017-2028) Figure 55. China Antidepressants Revenue (2017-2028) & (US$ Million) Figure 56. Japan Antidepressants Revenue (2017-2028) & (US$ Million) Figure 57. South Korea Antidepressants Revenue (2017-2028) & (US$ Million) Figure 58. India Antidepressants Revenue (2017-2028) & (US$ Million) Figure 59. Australia Antidepressants Revenue (2017-2028) & (US$ Million) Figure 60. Taiwan Antidepressants Revenue (2017-2028) & (US$ Million) Figure 61. Indonesia Antidepressants Revenue (2017-2028) & (US$ Million) Figure 62. Thailand Antidepressants Revenue (2017-2028) & (US$ Million) Figure 63. Malaysia Antidepressants Revenue (2017-2028) & (US$ Million) Figure 64. Philippines Antidepressants Revenue (2017-2028) & (US$ Million) Figure 65. Vietnam Antidepressants Revenue (2017-2028) & (US$ Million) Figure 66. Latin America Antidepressants Sales Market Share by Type (2017-2028) Figure 67. Latin America Antidepressants Revenue Market Share by Type (2017-2028) Figure 68. Latin America Antidepressants Sales Market Share by Application (2017-2028) Figure 69. Latin America Antidepressants Revenue Market Share by Application (2017-2028) Figure 70. Latin America Antidepressants Sales Share by Country (2017-2028) Figure 71. Latin America Antidepressants Revenue Share by Country (2017-2028) Figure 72. Mexico Antidepressants Revenue (2017-2028) & (US$ Million) Figure 73. Brazil Antidepressants Revenue (2017-2028) & (US$ Million) Figure 74. Argentina Antidepressants Revenue (2017-2028) & (US$ Million) Figure 75. Middle East and Africa Antidepressants Sales Market Share by Type (2017-2028) Figure 76. Middle East and Africa Antidepressants Revenue Market Share by Type (2017-2028) Figure 77. Middle East and Africa Antidepressants Sales Market Share by Application (2017-2028) Figure 78. Middle East and Africa Antidepressants Revenue Market Share by Application (2017-2028) Figure 79. Middle East and Africa Antidepressants Sales Share by Country (2017-2028) Figure 80. Middle East and Africa Antidepressants Revenue Share by Country (2017-2028) Figure 81. Turkey Antidepressants Revenue (2017-2028) & (US$ Million) Figure 82. Saudi Arabia Antidepressants Revenue (2017-2028) & (US$ Million) Figure 83. UAE Antidepressants Revenue (2017-2028) & (US$ Million) Figure 84. Antidepressants Value Chain Figure 85. Antidepressants Production Process Figure 86. Channels of Distribution Figure 87. Distributors Profiles Figure 88. Bottom-up and Top-down Approaches for This Report Figure 89. Data Triangulation Figure 90. Key Executives Interviewed

H Lundbeck Astrazeneca Eli Lilly and Company Sun Pharmaceuticals Pfizer Inc. GlaxoSmithKline Bristol-Myers Squibb Company Johnson & Johnson Merck Sanofi